TESARO is an oncology-focused biopharmaceutical company.
TESARO is dedicated to improving the lives of cancer patients by developing and providing safer and more effective therapeutics and supportive care products.
Contact
TESARO Bio GmbH.
Poststrasse 6
6300 ZUG
Switzerland
| www.tesarobio.com
|
Petra Exner and Tobias Haber discuss the unique service offering of INSIGHT Health, one of the leading data providers to the healthcare market, the company’s successful internationalization strategy, and why…
Rocco Donnino, executive vice president of corporate development of AppRiver AG, a cybersecurity company with headquarters in Switzerland and Florida, US, discusses the strategic steps in establishing AppRiver across Europe…
Thomas Huber, CEO of Skan Group in Switzerland, a global leader in clean room equipment for the life sciences industry, discusses adapting to an ever-changing regulatory environment, Skan’s unique solutions,…
In an exclusive interview, Jean-Paul Clozel, former head of Actelion and now CEO of exciting biotech newcomer Idorsia, discusses his new company’s unique drug discovery methodology, the pressure of past…
Thierry Mauvernay, president and delegate of the board of Debiopharm, discusses the Swiss Group’s development over its 38 years of history, its unique business strategy, and how new trends such…
Giacomo Di Nepi, CEO of innovative Swiss specialty pharma outfit Polyphor, discusses his decision to join the company in 2016, his main priorities, and the potential impact of an IPO…
Saad Harti, president of Legacy Healthcare, discusses the company’s origins, their unique focus on side-effect free botanical drugs for chronic conditions, and the importance of stakeholder education in this exciting…
Philippe Held, founder of the innovative Swiss medtech Dermosafe, discusses the origins behind the company’s game-changing digitalized solutions for detecting skin cancer at an early stage, how the rollout of…
Vicky Levy, head of life sciences and healthcare at Deloitte Switzerland provides a fascinating insight into the life sciences sectors on both sides of the Atlantic Ocean whilst also detailing…
Paul Note, CEO of leading Swiss tissue and bone regeneration specialist Geistlich, discusses how the medtech industry can safeguard success against a challenging economic backdrop, the company’s total commitment to…
Matthias Suhr, director of EuroAirport near Basel discusses the merits of operating in a bi-national environment, how the airport has acquired the latest industry accreditation, and how the pharmaceutical industry…
Roel Van Doren provides a fascinating insight into the interplay between the life sciences and industrial automation sectors in Europe, whilst also detailing Emerson’s footprint in Switzerland and beyond, as…
See our Cookie Privacy Policy Here
